Daunorubicin liposomal
At a glance
- Drug Originator Gilead Sciences
- Drug Licenced by Diatos
- Drug Class Anthracyclines; Antineoplastics; Cytostatic antibiotics
- Mechanism of Action Apoptosis stimulants; RNA synthesis inhibitors
- USA Patent Applicants GALEN (UK)
- NDAs 1
- Patent Applications 4,471
Table of Contents
Disclaimer